SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lorus Therapeutics Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trustmanic who wrote (15)2/18/1997 10:20:00 AM
From: ROY PHUNG   of 279
 
To all
Here is one article about IMT you might be interested.

Globe says new v-p was a good stock picker

Imutec Pharma Inc IMTShares issued 225146321997-02-12 close $1.25Thursday Feb 13 1997In the NewsThe Globe and Mail reports in its Thursday edition that biotech analyst Bin Huang has decided to trade her business suits for a lab coat. Streetwise columnist Andrew Willis says the veteran analyst joined cancer treatment researcher Imutec Pharma this week as v-p of research and development. Dr Huang jumped from one of the more successful firms on Bay Street. She was biotech and life sciences analyst at Griffiths McBurney & Partners for the past year. Prior to that, she was with Credifinance Securities, another institutional brokerage in Toronto that had underwritten Imutec financings. Greg Misztela, head of research at Griffiths McBurney, says that Dr Huang had a great opportunity to do clinical research, which is her first love. For Griffiths McBurney, this marks the first time that a partner has left the brokerage, which was founded just more than a year ago. After earning a PhD from Britain's University of East Anglia, she spent six years doing crop research with Pioneer Hi-Bred. (c) Copyright 1997 Canjex Publishing Ltd. canada-stockwatch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext